The Eczema Therapeutics Market provides relief for the chronic inflammatory skin condition eczema. Topical corticosteroids, calcineurin inhibitors, and antihistamines are commonly prescribed short-term treatment options to reduce itching, flaking, cracks, sores and swelling.
The Global Eczema Therapeutics Market is estimated to be valued at US$ 21973.78 Bn in 2024 and is expected to exhibit a...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian